Digestive Diseases and Sciences

, Volume 51, Issue 2, pp 370–373

Association Between Helicobacter pylori Infection and Cirrhosis in Patients with Chronic Hepatitis C Virus

  • Dulciene Maria Magalhães Queiroz
  • Andreia Maria Camargos Rocha
  • Gifone Aguiar Rocha
  • Sarah Maria Singulano Cinque
  • Adriana Gonçalves Oliveira
  • Alicia Godoy
  • Hugo Tanno


We evaluated, employing a logistic regression model, the association between Helicobacter pylori infection and cirrhosis in a cohort of 106 patients (57 males; mean age, 52.9 years; range, 20–78 years) with chronic hepatitis C virus (HCV) from Rosario, Argentina. HCV was confirmed by ELISA and PCR. H. pylori status was determined by ELISA. Of the 106 patients evaluated, 47 (44.3%) had cirrhosis. A total of 70.2% (33/47) of cirrhotic patients and 47.5% (28/59) of noncirrhotic patients were H. pylori-positive. In univariate analyses, cirrhosis was associated with age (P = 0.016) and H. pylori-positive status (P = 0.019) but not with gender (P = 0.28) or length of infection (P = 0.35). In multivariate analysis, H. pylori infection (P = 0.037; OR = 2.42; 95% CI = 1.06–5.53) and age (P = 0.033; OR = 1.04; 95% CI = 1.00–1.07) of patients remained significant and independently associated with cirrhosis. In conclusion, our results demonstrate an association between H. pylori infection and cirrhosis in patients with hepatitis C virus.

Key Words

hepatitis C virus cirrhosis pathogenesis Helicobacter pylori 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kawai H, Feinstone S: Acute viral hepatits. In. Principle and Practice of Infectious Diseases. Mandell GL, Douglas RG, Benett JE (eds). New York, Churchill Livingstone, 2000, pp 1279–1292Google Scholar
  2. 2.
    Alter MJ: The epidemiology of hepatitis C in the west. Semin Liver Dis 15:5–14, 1995PubMedGoogle Scholar
  3. 3.
    Hopf U, Moller B, Kuther D: Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 10:69–76, 1990CrossRefPubMedGoogle Scholar
  4. 4.
    Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshisawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH: Interrelatonship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibodies to hepatitis C virus. Hepatology 12:671–675, 1990PubMedGoogle Scholar
  5. 5.
    Tong MJ, El-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463–1366, 1995CrossRefPubMedGoogle Scholar
  6. 6.
    Corrao G, Aricò S: Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 27:914–919, 1998CrossRefPubMedGoogle Scholar
  7. 7.
    Poynard T, Bedossa P, Oplon P: Natural history of liver fibbrosis progression in patients with chronic hepatitis C. Lancet 349:825–832, 1997CrossRefPubMedGoogle Scholar
  8. 8.
    EASL Internacional Consensus Conference on Hepatitis C: Consensus statement. J Hepatol 30:956–961, 1999Google Scholar
  9. 9.
    Saccheti C, Capello M, Rebecchi P, Roncucci L, Zanghieri G, Tripodi A, Ponz de Leon M: Frequency of upper gastointestinal lesions in patients with liver cirrhosis. Dig Dis Sci 33:1218–1222, 1988Google Scholar
  10. 10.
    Rabinovitz M, Yoo Y-K, Schade RR, Dindzans VJ, Van Thiel DH, Gavaler JS: Prevalence of endoscopic findings in 510 consecutive individuals with cirrhosis evaluated propectively. Dig Dis Sci 35:705–710, 1990PubMedGoogle Scholar
  11. 11.
    Mégraud F, Lamouliatte H: Helicobacter pylori. and duodenal ulcer. Dig Dis Sci 37:769–772, 1992CrossRefPubMedGoogle Scholar
  12. 12.
    Siringo S, Burrouhgs AK, Bolondi L, Muia A, Di Febo G, Miglioloi M, Cavalli G, Barbara L: Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol 22:633–641, 1995CrossRefPubMedGoogle Scholar
  13. 13.
    Solnick JV, Schauer DB: Emergence of diverse Helicobacter. species in the pathogenesis of gastric and enterohepatic diseases. Clin Microbiol Rev 14:59–97, 2001CrossRefPubMedGoogle Scholar
  14. 14.
    Lin TT, Yeh CT, Wu CS, Liaw YF: Detection and partial sequence analysis of Helicobacter pylori. DNA in the bile samples. Dig Dis Sci 40:2214–2219, 1995PubMedGoogle Scholar
  15. 15.
    Avenaud P, Marais A, Monteiro L, Le Bail B, Bioulac Sage P, Balabaud C, Mégraud F: Detection of Helicobacter. species in the liver of patients with and without primary liver carcinoma. Cancer 89:1431–1439, 2000CrossRefPubMedGoogle Scholar
  16. 16.
    Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadstrom T: Identification of Helicobacter pylori. and other Helicobacter. species by PCR, hydridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 38:1072–1076, 2000PubMedGoogle Scholar
  17. 17.
    Nilsson H-O, Mulchandani R, Tranberg KG, Wadstrom T: Helicobacter. species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma. Gastroenterology 120:323–324, 2001PubMedGoogle Scholar
  18. 18.
    Queiroz DMM, Santos A, Oliveira AG, Rocha GA, Moura SB, Camargo ERS, Valle PR, Bicalho LAF, Dani R: Isolation of a Helicobacter. strain from the human liver. Gastroenterology 121:1023–1028, 2001Google Scholar
  19. 19.
    Siringo S, Vaira D, Menegatti M, Piscaglia F, Sofia S, Caetani M, Miglioli M, Corinaldesi R, Bolondi L: High prevalence of Helicobacter pylori. in liver cirrhosis: Relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci 42:2024–2030, 1997PubMedGoogle Scholar
  20. 20.
    Ponzetto A, Pellicano R, Leone N, Cutufia MA, Turrini F, Grigioni WF, D'Errico A, Mortimer P, Rizzeto M, Silengo L: Helicobacter. infection and cirrhosis in hepatitis C virus carriage: Is it an innocent bystander or a troublemarker? Med Hypotheses 54:275–277, 2000CrossRefPubMedGoogle Scholar
  21. 21.
    Pellicano R, Leone N, Berrutti M, Cutufuia MA, Fiorentino M, Rizzeto M, Ponzetto A: Helicobacter pylori. seroprevalence in hepatitis C virus positive patients with cirrhosis. J Hepatol 33:648–650, 2000CrossRefPubMedGoogle Scholar
  22. 22.
    Rocha GA, Oliveira AMR, Queiroz DMM, Mendes EN, Moura SB, Oliveira CA, Ferrari TC: Serodiagnosis of Helicobacter pylori. infection by Cobas Core ELISA in adults from Minas Gerais, Brazil. Brazil J Med Biol Res 31:1263–1268, 1998Google Scholar
  23. 23.
    Roudot-Thoraval F, Bastie A, Pawlotisky JM, Dhumeaux D: Epidemiological features affecting the severity of hepatitis C virus-related liver diseases: A French survey of 6,664 patients. Hepatology 26:485–490, 1997CrossRefPubMedGoogle Scholar
  24. 24.
    Pesti PS, Corti R, Bedram R, Varela A, Glanczpigel R, Scharaies M: Serum prevalence of Helicobacter pylori. infection in the Republic of Argentine: Influence of age, sex, socioeconomic level, geographical area and health infrastructure. Multicenter Study by The Club Argentino del Estomago y Duodeno. Acta Gastroenterol Latinoam 29:297–305, 1999Google Scholar
  25. 25.
    Argentinean Hp Epidemiologic Study Group: Prevalence of Helicobacter pylori. in Argentina: Results of a nationwide epidemiologic study. J Clin Gastroenterol 31:33–37, 2000Google Scholar
  26. 26.
    Langenberg W, Raws EAJ, Oudbier JH, Tytgat GN: Patient-to-patient transmission of Campylobacter pylori. infection by fiberoptic gastroduodenoscopy and biopsy. J Infect Dis 161:507–511, 1990PubMedGoogle Scholar
  27. 27.
    Tytgat GNJ: Endoscopic transmission of Helicobacter pylori.. Aliment Pharmacol Ther 9 (Suppl 2):41–44, 1995Google Scholar
  28. 28.
    Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytigat GN: Mucosal tumor necrosis factor-alfa, interleukin-1, beta and interleukin-8 production in patients with Helicobacter pylori.. Scnd J Gastroenterol 29:419–424, 1994Google Scholar
  29. 29.
    Crabtree JE, Shallcroos TM, Heatley RV, Wyatt JI: Mucosal tumor necrosis factor x interleucin-6 in patients with Helicobacter pylori. associated gastritis. Gut 32:1473–1477, 1991PubMedGoogle Scholar
  30. 30.
    Karttunen R, Karttunen T, Ekre HP, MacDonald TT: Interferon gamma and interleukin-4 secreting cells in the gastric antrum in Helicobacter pylori. positive and negative gastritis. Gut 36:341–345, 1995PubMedGoogle Scholar
  31. 31.
    Fox JG: Hepatobiliary helicobacters: Recognized animals pathogens with suspected pathogenic potential in humans. In Helicobacter pylori.: Basic Mechanisms to Clinical Cure 2000. Hunt H, Tytgat GN (eds). Dordrecht, the Netherlands, Kluwer Academic, 2000, pp 83–104Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  • Dulciene Maria Magalhães Queiroz
    • 1
    • 4
  • Andreia Maria Camargos Rocha
    • 1
  • Gifone Aguiar Rocha
    • 1
  • Sarah Maria Singulano Cinque
    • 1
  • Adriana Gonçalves Oliveira
    • 2
  • Alicia Godoy
    • 3
  • Hugo Tanno
    • 3
  1. 1.Laboratory of Research in Bacteriology, Faculdade de MedicinaUniversidade Federal de Minas GeraisBelo Horizonte
  2. 2.Faculdade de Medicina do Triângulo MineiroBrasil
  3. 3.Servicio de Gastroenterologia del Hospital CentenarioUniversidad Nacional de RosarioRosarioArgentina
  4. 4.Faculdade de Medicina da Universidade Federal de Minas GeraisBelo HorizonteArgentina

Personalised recommendations